Experian acquired NeuroID to add behavioral analytics to its enterprise fraud-prevention tools. NeuroID analyzes how users interact with online forms and other digital flows, giving businesses another set of risk signals alongside identity, device, and network data. Experian announced the deal on August 13, 2024; a later filing says it closed the previous day.
What Experian acquired—and when
Experian’s public announcement came on August 13, 2024. Its later acquisition disclosure records the closing date as August 12, 2024, and says Experian acquired 100% of Neuro-ID, Inc. for US$145 million in cash consideration. That amount is the consideration reported for acquisition accounting, not a separate estimate of the company’s value. Experian’s announcement and its 2025 acquisition disclosure distinguish the announcement from the completed transaction.
Why NeuroID fit Experian’s fraud business
NeuroID offered a behavioral layer for fraud screening: information about how someone interacts with a digital process, rather than only information about who they claim to be or which device or network they use. Experian positioned those signals as a complement to its existing data, device, and network intelligence, helping business customers assess risk during account opening, logins, and transactions. Experian’s acquisition announcement describes that product rationale.
The commercial relationship already existed before the purchase. On December 5, 2023, Experian said NeuroID was available through its fraud-prevention offerings, including CrossCore and Precise ID. The acquisition therefore formalized and extended an existing product relationship rather than introducing NeuroID to Experian’s platform for the first time. Experian’s 2023 announcement describes that earlier availability.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
#1 Best Overall
How behavioral analytics can contribute to fraud screening
Experian says NeuroID observes real-time interactions such as how a user navigates a form and enters information. Its 2025 annual report gives examples of behavior that may merit closer scrutiny: copying and pasting details, switching between apps, completing a form unusually quickly, or taking delays and making repeated corrections while entering information. Experian also describes looking for devices associated with multiple fraud attempts. These are potential risk indicators, not proof that an individual is committing fraud; a legitimate user can also behave unusually. Experian’s 2025 annual report explains the examples.
In a broader workflow, a business could consider behavioral interactions alongside device and network intelligence, identity verification, and fraud scores. Experian describes combining these layers to help identify possible identity theft, fraud rings, and AI-enabled bots. Those are company-described capabilities and use cases, not independent measurements of accuracy or evidence that any single signal reliably identifies a particular threat. Experian’s 2023 product announcement outlines the stated use cases.
Where NeuroID sits in Experian’s products
At the time of its acquisition announcement, Experian said NeuroID was available through CrossCore on the Experian Ascend Technology Platform. In its FY2025 reporting, Experian described NeuroID as part of its fraud suite and said the capability had been added to Ascend. These descriptions place behavioral analytics inside a wider business fraud-prevention offering; they do not establish a separate consumer-facing NeuroID product. The acquisition announcement and FY2025 reporting describe the integration.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What the acquisition does—and does not—show
The deal shows Experian’s strategic interest in adding behavioral signals to its fraud tools. It does not, by itself, show that the technology reduced fraud by a particular amount. Experian’s announcement cited an estimated US$15 billion in global fraud losses avoided in the prior year by its identity-verification and fraud-prevention solutions overall; that was Experian’s estimate for the broader solutions, not a NeuroID-specific result. The official materials cited here do not report an independent post-acquisition study, a NeuroID-specific fraud-reduction rate, or customer adoption figures that would establish measured results. Experian’s announcement gives the company estimate, while its 2025 annual report describes the product capabilities.
Quick Recap
Best Value
Rank #4
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
